In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: Correlation with penicillin resistance

Clinical Therapeutics

Volumn 20, Issue 6, 1998, Pages 1179-1190

  Thornsberry, Clyde ^a   Ogilvie, Penny T ^a,b   Holley Jr , H Preston ^c   Sahm, Daniel F ^d  

^a MRL Pharmaceutical Services   (United States)

^b Home Healthcare Labs of America   (United States)

^c GLAXOSMITHKLINE   (United States)

^d MRL Pharmaceutical Services   (United States)

Author keywords

Antibiotic resistance; Grepafloxacin; In vitro susceptibility; Penicillin; Pneumococci

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CEFACLOR; CEFALOTIN; CEFIXIME; CEFPROZIL; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GREPAFLOXACIN; LEVOFLOXACIN; LINCOSAMIDE; LORACARBEF; MACROLIDE; OFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPARFLOXACIN; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; CONFERENCE PAPER; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032417797     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80113-6     Document Type: Conference Paper

References (12)

1. 1. Klein JO. Selection of oral antimicrobial agents for otitis media and pharyngitis. Infect Dis Clin Pract. 1995;4(Suppl 2): S88-S94.
2. 2. Hansman D, Bullen MM. A resistant pneumococcus. Lancet. 1967;2:264-265. Letter.
3. 3. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ. Antimicrobial resistance of Streptococcus pneumoniae in the United States. J Infect Dis. 1991;163:1273-1278.
4. 4. Thornsberry C, Ogilvie P, Kahn J, et al. Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. Diagn Microbiol Infect Dis. 1997;29:249-257.
5. 5. Baron EJ, Murray PR. Bacteriology. In: Murray PR, Baron EJ, Pfaller MA, et al, eds. Manual of Clinical Microbiology, 6th ed. Washington, DC: American Society for Microbiology; 1995:246-662.
6. 6. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Document M7-A4. 4th ed. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1997.
7. 7. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: Results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208-1213.
8. 8. Thornsberry C, Brown SD, Yee YC, et al. Increasing penicillin resistance in Streptococcus pneumoniae in the U.S. Infect Med. 1993;12(Suppl):S15-S24.
9. 9. Thornsberry C, Burton PH, Vanderhoof BH. Activity of penicillin and three third-generation cephalosporins against U.S. isolates of Streptococcus pneumoniae: A 1995 surveillance study. Diagn Microbiol Infect Dis. 1996;25:89-95.
10. 10. Zighelboim S, Tomasz A. Penicillin-binding protein of multiply antibiotic-resistant South African strains of Streptococcus pneumoniae. Antimicrob Agents Chemother. 1980;17:434-442.
11. 11. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990;3:171-196.
12. 12. Bartlett JG, Breiman RF, Mandell LA, File TM. Community-acquired pneumonia in adults: Guidelines for management. Clin Infect Dis. 1998;26:811-838.